Project Grant R01HD119756
- Federal Grant Award Summary Baylor College of Medicine received a $601,082 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded May 15, 2026, with completion targeted for February 28, 2031. The research focuses on elucidating the role of the mir302 family of microRNAs in regulating neural development and congenital hydrocephalus (CH), a condition characterized by...
- Federal Grant Award Summary Baylor College of Medicine received a $425,015 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) with an award date of August 1, 2025, and completion date of July 31, 2027. The research project investigates interindividual epigenetic variation at birth and its association with subsequent risk of dysbiosis and necrotizing enterocolitis (NEC) in...
- Federal Grant Award Summary Baylor College of Medicine received a $626,429 Project Grant award effective July 1, 2025, through May 31, 2030, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds research investigating the role of Carbohydrate Responsive Element Binding Protein (ChREBP), a transcription factor implicated in metabolic-associated steatohepatitis,...
- Federal Grant Award Summary Baylor College of Medicine received a $311,488 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) effective September 1, 2025, with completion targeted for April 16, 2028. The award supports investigative research into the mechanisms linking iron homeostasis dysregulation and ferroptosis (iron-dependent cell death) to endometriosis and early...
- Federal Grant Award Summary Baylor College of Medicine received a $200,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the project "Structural Proteome Diversity as a Determinant of Hematopoietic Aging." The award was obligated on September 15, 2025, with a completion date of August 31, 2026. The research is being conducted in...
- Federal Grant Award Summary Baylor College of Medicine received an $882,138 Project Grant award effective September 1, 2025, through June 30, 2030, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports the Houston Area Incubator for Kidney, Urologic, and Hematologic Research Training (HAI-KUH), a training core designed to develop a qualified workforce in...
- Federal Project Grant Summary Baylor College of Medicine received a $152,300 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective March 1, 2026 through February 28, 2029. The award supports research investigating how the diabetic urinary environment modulates Group B Streptococcus (GBS) virulence and host immune responses, with particular focus on...
- Federal Project Grant Award Summary Baylor College of Medicine received a $326,614 project grant awarded June 20, 2025, by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research to advance understanding of kynurenine 3-monooxygenase (KMO) deficiency as a novel congenital nicotinamide adenine dinucleotide (NAD) deficiency disorder. The research utilizes two mouse...
- Federal Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded Baylor University a $542,102 Project Grant effective September 1, 2025, through August 31, 2028, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award supports a randomized crossover research study evaluating the efficacy of an activities-based locomotor training (AB-LT) program for non-ambulatory children aged 2-6 years with cerebral palsy. The...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $249,000 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective July 1, 2025 through June 30, 2028. The award supports research on in utero intervention strategies designed to prevent adverse metabolic health outcomes in adulthood. The research addresses non-communicable...
Baylor College of Medicine received a $695,659 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective May 15, 2026, through February 28, 2031. The award supports research investigating adrenomedullin's (ADM) pathophysiological role in gestational diabetes mellitus (GDM) using innovative mouse models and pharmacological approaches. The research aims to elucidate mechanisms by which elevated ADM levels contribute to GDM symptoms through beta-cell dysfunction and adipose tissue dysregulation, with three complementary aims employing inducible genetic models and receptor knockout approaches to assess ADM signaling in pregnancy-related metabolic adaptations. The research addresses a significant clinical gap in GDM treatment, as current therapies focus exclusively on glucose control while neglecting adipose tissue dysfunction. This project will generate evidence supporting adrenomedullin antagonism as a novel therapeutic strategy targeting underlying GDM mechanisms rather than symptomatic glucose management alone. The work is conducted at Baylor College of Medicine in Houston, Texas, leveraging the institution's extensive biomedical research capabilities in metabolic disease and pregnancy-related outcomes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $695.7k | 5/12/26 |